Order Article Reprints

Saber S, Alamri MMS, Alfaifi J, Saleh LA, Abdel-Ghany S, Aboregela AM, Farrag AA, Almaeen AH, Adam MIE, AlQahtani AAJ, et al. Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953. Pharmaceuticals. 2025; 18(1):93. https://doi.org/10.3390/ph18010093

Saber, Sameh, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Lobna A. Saleh, Sameh Abdel-Ghany, Adel Mohamed Aboregela, Alshaimaa A. Farrag, Abdulrahman H. Almaeen, Masoud I. E. Adam, AbdulElah Al Jarallah AlQahtani, and et al. 2025. "Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953" Pharmaceuticals 18, no. 1: 93. https://doi.org/10.3390/ph18010093

Saber, S., Alamri, M. M. S., Alfaifi, J., Saleh, L. A., Abdel-Ghany, S., Aboregela, A. M., Farrag, A. A., Almaeen, A. H., Adam, M. I. E., AlQahtani, A. A. J., Eleragi, A. M. S., Abdel-Reheim, M. A., Ramadan, H. A., & Mohammed, O. A. (2025). Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953. Pharmaceuticals, 18(1), 93. https://doi.org/10.3390/ph18010093